RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

BACKGROUND: Gemcitabine has been widely used as a chemotherapeutic drug. However, drug resistance, short half-life and side effects seriously decrease its chemotherapeutic efficacy. PURPOSE: The object of preparing RGDV-gemcitabine was to prolong the half-life, to overcome drug resistance and to eli...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenchao, Mao, Yujia, Zhang, Xiaoyi, Wang, Yaonan, Wu, Jianhui, Zhao, Shurui, Peng, Shiqi, Zhao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737205/
https://www.ncbi.nlm.nih.gov/pubmed/31686807
http://dx.doi.org/10.2147/IJN.S212978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737205/
https://www.ncbi.nlm.nih.gov/pubmed/31686807
http://dx.doi.org/10.2147/IJN.S212978

Ejemplares similares